Department of Affective Disorders, Aarhus University Hospital - Psychiatry, Aarhus, Denmark.
Department of Political Science, University of Copenhagen, Copenhagen, Denmark.
Acta Neuropsychiatr. 2021 Oct;33(5):273-276. doi: 10.1017/neu.2021.15. Epub 2021 May 17.
Patients with mental illness are at an increased risk of COVID-19 infection, morbidity, and mortality, and prioritisation of this group for COVID-19 vaccination programmes has therefore been suggested. Vaccine uptake may, however, be compromised by vaccine hesitancy amongst patients with mental illness, posing a critical public health issue. We conducted two surveys to provide weighted estimates of vaccine willingness amongst patients with mental illness and the general population of Denmark. Vaccine willingness was high in both groups, but slightly lower amongst patients with mental illness (84.8%), compared with the general population (89.5%) (p < .001). Based on these findings, vaccine hesitancy does not appear to be a major barrier for vaccine uptake amongst patients with mental illness in Denmark, but may be so in other countries with lower general vaccine willingness. Replication of the present study in other countries is strongly warranted.
患有精神疾病的患者感染 COVID-19、出现发病和死亡的风险增加，因此建议将这一群体作为 COVID-19 疫苗接种计划的优先对象。然而，精神疾病患者的疫苗犹豫可能会影响疫苗接种率，这构成了一个关键的公共卫生问题。我们进行了两项调查，以提供丹麦精神疾病患者和普通人群疫苗接种意愿的加权估计。两组人群的疫苗接种意愿都很高，但精神疾病患者（84.8%）的接种意愿略低于普通人群（89.5%）（p<.001）。基于这些发现，疫苗犹豫似乎不是丹麦精神疾病患者疫苗接种的主要障碍，但在疫苗总体接种意愿较低的其他国家可能是一个障碍。强烈需要在其他国家复制本研究。
